- Home
- TTNP vs SNOA Comparison
TTNP vs SNOA Comparison
Compare TTNP & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- SNOA
- Stock Information
- Founded
- TTNP 1991
- SNOA 1999
- Country
- TTNP United States
- SNOA United States
- Employees
- TTNP N/A
- SNOA N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- SNOA Health Care
- Exchange
- TTNP Nasdaq
- SNOA Nasdaq
- Market Cap
- TTNP 3.4M
- SNOA 3.6M
- IPO Year
- TTNP 1996
- SNOA 2007
- Fundamental
- Price
- TTNP $3.59
- SNOA $3.08
- Analyst Decision
- TTNP
- SNOA
- Analyst Count
- TTNP 0
- SNOA 0
- Target Price
- TTNP N/A
- SNOA N/A
- AVG Volume (30 Days)
- TTNP 58.6K
- SNOA 4.5M
- Earning Date
- TTNP 03-31-2025
- SNOA 02-05-2025
- Dividend Yield
- TTNP N/A
- SNOA N/A
- EPS Growth
- TTNP N/A
- SNOA N/A
- EPS
- TTNP N/A
- SNOA N/A
- Revenue
- TTNP N/A
- SNOA $13,973,000.00
- Revenue This Year
- TTNP N/A
- SNOA $23.89
- Revenue Next Year
- TTNP N/A
- SNOA $25.45
- P/E Ratio
- TTNP N/A
- SNOA N/A
- Revenue Growth
- TTNP N/A
- SNOA 13.51
- 52 Week Low
- TTNP $3.03
- SNOA $1.90
- 52 Week High
- TTNP $14.80
- SNOA $9.40
- Technical
- Relative Strength Index (RSI)
- TTNP 48.42
- SNOA 61.41
- Support Level
- TTNP $3.20
- SNOA $1.90
- Resistance Level
- TTNP $4.39
- SNOA $4.46
- Average True Range (ATR)
- TTNP 0.47
- SNOA 0.39
- MACD
- TTNP -0.05
- SNOA 0.13
- Stochastic Oscillator
- TTNP 30.23
- SNOA 46.09
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.